Viewing Study NCT00002420


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2025-12-26 @ 3:06 AM
Study NCT ID: NCT00002420
Status: TERMINATED
Last Update Posted: 2008-08-14
First Post: 1999-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module